# A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations

> **NCT06052267** · PHASE3 · RECRUITING · sponsor: **Teva Branded Pharmaceutical Products R&D LLC** · enrollment: 2700 (estimated)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** TEV-56248
- **DRUG:** Albuterol sulfate

## Key facts

- **NCT ID:** NCT06052267
- **Lead sponsor:** Teva Branded Pharmaceutical Products R&D LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-30
- **Primary completion:** 2026-10-31
- **Final completion:** 2026-10-31
- **Target enrollment:** 2700 (ESTIMATED)
- **Last updated:** 2026-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06052267

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06052267, "A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06052267. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*